Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-19-100784
Filing Date
2019-04-08
Accepted
2019-04-08 16:46:59
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3/A d626180ds3a.htm S-3/A 454493
2 EX-23.1 d626180dex231.htm EX-23.1 1954
3 EX-99.1 d626180dex991.htm EX-99.1 32748
4 EX-99.2 d626180dex992.htm EX-99.2 10796
5 EX-99.3 d626180dex993.htm EX-99.3 11134
6 EX-99.4 d626180dex994.htm EX-99.4 8452
7 EX-99.5 d626180dex995.htm EX-99.5 22696
8 EX-99.6 d626180dex996.htm EX-99.6 17960
9 EX-99.7 d626180dex997.htm EX-99.7 14360
10 GRAPHIC g626180g0305202043518.jpg GRAPHIC 3284
  Complete submission text file 0001193125-19-100784.txt   580398
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-230085 | Film No.: 19737804
SIC: 2834 Pharmaceutical Preparations